BridgeMD
New treatment option for Stroke
Official title Personalised Health Motor and Cognitive Assistance System for RehAbilitation (PHRASE)
ClinicalTrials.gov ID: NCT06885502
What this study is testing
- What it's testing
- This study is a multicentric randomized controlled trial evaluating the effectiveness of digital technology, specifically a smartphone with integrated VR-and AR-based intervention, for at-home rehabilitation after stroke. The study focuses on combined motor and cognitive training for patients in the late subacute and chronic phases post-stroke.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients presenting an ischemic or intracerebral haemorrhagic stroke, ≥ 3 months post-stroke.
- Age \> 18 years old
- Moderate to mild proximal upper limb motor impairment Medical Research Council Scale (MRC \>2).
- ARAT: \<50, inclusive, to avoid ceiling effects while allowing room for improvement.
- Able to sit on a chair or a wheelchair to interact with the RGS system.
You likely can't join if
- Presence of a condition or abnormality that, in the opinion of the investigator, would compromise the safety of the patient or the quality of the...
- Severe cognitive capabilities that prevent the execution of the study, evaluated by the MoCA \< 19 or based on the clinician's opinion.
- Pre-stroke history of upper limb motor disability.
- Unable to use the RGS independently, according to the clinician's observations, and needing more support from a caregiver to use the RGS.
See the full eligibility criteria
- Patients presenting an ischemic or intracerebral haemorrhagic stroke, ≥ 3 months post-stroke.
- Age \> 18 years old
- Moderate to mild proximal upper limb motor impairment Medical Research Council Scale (MRC \>2).
- ARAT: \<50, inclusive, to avoid ceiling effects while allowing room for improvement.
- Able to sit on a chair or a wheelchair to interact with the RGS system.
- Minimal experience with smartphone technology based on the clinician's opinion
- Willing to participate and agree to comply with the trial scheme and procedures
- Must sign an Informed Consent Form (ICF) indicating that they understand the purpose and the procedures of the study.
- Presence of a condition or abnormality that, in the opinion of the investigator, would compromise the safety of the patient or the quality of the data.
- Severe cognitive capabilities that prevent the execution of the study, evaluated by the MoCA \< 19 or based on the clinician's opinion.
- Pre-stroke history of upper limb motor disability.
- Unable to use the RGS independently, according to the clinician's observations, and needing more support from a caregiver to use the RGS.
The study team makes the final eligibility decision.
Where it's taking place
- Cluj-Napoca, Romania
- Tarragona, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cluj-Napoca, Romania; Tarragona, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.